A
13.39
0.59 (4.61%)
| Penutupan Terdahulu | 12.80 |
| Buka | 12.94 |
| Jumlah Dagangan | 356,419 |
| Purata Dagangan (3B) | 1,645,569 |
| Modal Pasaran | 415,978,240 |
| Harga / Buku (P/B) | 3.74 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| EPS Cair (TTM) | -2.30 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.01% |
| Nisbah Semasa (MRQ) | 22.53 |
| Aliran Tunai Operasi (OCF TTM) | -53.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -39.36 M |
| Pulangan Atas Aset (ROA TTM) | -22.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -38.04% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Alto Neuroscience, Inc. | Menaik | Menaik |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 0.5 |
| Purata | 0.50 |
|
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals’ neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 7.48% |
| % Dimiliki oleh Institusi | 77.52% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Alpha Wave Global, Lp | 30 Sep 2025 | 3,707,757 |
| Armistice Capital, Llc | 30 Sep 2025 | 1,636,000 |
| Vestal Point Capital, Lp | 30 Sep 2025 | 950,000 |
| 72 Investment Holdings, Llc | 30 Sep 2025 | 667,778 |
| Alkeon Capital Management Llc | 30 Sep 2025 | 477,101 |
| Integral Health Asset Management, Llc | 30 Sep 2025 | 400,000 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 50.00 (HC Wainwright & Co., 273.41%) | Beli |
| Median | 25.00 (86.71%) | |
| Rendah | 15.00 (Chardan Capital, 12.02%) | Beli |
| Purata | 27.80 (107.62%) | |
| Jumlah | 5 Beli | |
| Harga Purata @ Panggilan | 10.87 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 17 Nov 2025 | 27.00 (101.64%) | Beli | 13.80 |
| Baird | 13 Nov 2025 | 22.00 (64.30%) | Beli | 11.35 |
| 20 Oct 2025 | 16.00 (19.49%) | Beli | 11.00 | |
| Jefferies | 12 Nov 2025 | 25.00 (86.71%) | Beli | 14.20 |
| HC Wainwright & Co. | 24 Oct 2025 | 50.00 (273.41%) | Beli | 11.00 |
| Chardan Capital | 29 Sep 2025 | 15.00 (12.02%) | Beli | 4.01 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |